nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine barbiturate—GABRA2—GABA A receptor activation—GABRQ—attention deficit hyperactivity disorder	0.0359	0.0607	CbGpPWpGaD
Quinidine barbiturate—GABRA1—GABA A receptor activation—GABRQ—attention deficit hyperactivity disorder	0.0306	0.0518	CbGpPWpGaD
Quinidine barbiturate—KCNK1—forebrain—attention deficit hyperactivity disorder	0.0245	0.0613	CbGeAlD
Quinidine barbiturate—GABRA2—Ligand-gated ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.022	0.0372	CbGpPWpGaD
Quinidine barbiturate—KCNK1—cardiovascular system—attention deficit hyperactivity disorder	0.0207	0.0518	CbGeAlD
Quinidine barbiturate—GRIA2—forebrain—attention deficit hyperactivity disorder	0.0199	0.0499	CbGeAlD
Quinidine barbiturate—GABRA1—Ligand-gated ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.0187	0.0317	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Interaction between L1 and Ankyrins—ANK3—attention deficit hyperactivity disorder	0.0177	0.0301	CbGpPWpGaD
Quinidine barbiturate—KCNK1—midbrain—attention deficit hyperactivity disorder	0.0162	0.0405	CbGeAlD
Quinidine barbiturate—KCNK1—nervous system—attention deficit hyperactivity disorder	0.0133	0.0333	CbGeAlD
Quinidine barbiturate—GRIA2—midbrain—attention deficit hyperactivity disorder	0.0132	0.0329	CbGeAlD
Quinidine barbiturate—GABRA2—forebrain—attention deficit hyperactivity disorder	0.0129	0.0324	CbGeAlD
Quinidine barbiturate—KCNK1—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.0128	0.0217	CbGpPWpGaD
Quinidine barbiturate—KCNK1—central nervous system—attention deficit hyperactivity disorder	0.0128	0.032	CbGeAlD
Quinidine barbiturate—GABRA1—forebrain—attention deficit hyperactivity disorder	0.0125	0.0313	CbGeAlD
Quinidine barbiturate—KCNK1—cerebellum—attention deficit hyperactivity disorder	0.0125	0.0313	CbGeAlD
Quinidine barbiturate—CHRM2—forebrain—attention deficit hyperactivity disorder	0.0124	0.0312	CbGeAlD
Quinidine barbiturate—SCN5A—cardiovascular system—attention deficit hyperactivity disorder	0.0124	0.0309	CbGeAlD
Quinidine barbiturate—GABRA2—GABA receptor activation—GABRQ—attention deficit hyperactivity disorder	0.0117	0.0197	CbGpPWpGaD
Quinidine barbiturate—GRIA2—nervous system—attention deficit hyperactivity disorder	0.0108	0.0271	CbGeAlD
Quinidine barbiturate—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.0105	0.0263	CbGeAlD
Quinidine barbiturate—GRIA2—central nervous system—attention deficit hyperactivity disorder	0.0104	0.0261	CbGeAlD
Quinidine barbiturate—GRIA2—cerebellum—attention deficit hyperactivity disorder	0.0102	0.0255	CbGeAlD
Quinidine barbiturate—KCNK1—brain—attention deficit hyperactivity disorder	0.0102	0.0254	CbGeAlD
Quinidine barbiturate—GRIA2—Hypothetical Network for Drug Addiction—DRD1—attention deficit hyperactivity disorder	0.0101	0.0172	CbGpPWpGaD
Quinidine barbiturate—GABRA1—GABA receptor activation—GABRQ—attention deficit hyperactivity disorder	0.00993	0.0168	CbGpPWpGaD
Quinidine barbiturate—Phenobarbital—CHRNA4—attention deficit hyperactivity disorder	0.0099	1	CrCbGaD
Quinidine barbiturate—GRIA2—Hypothetical Network for Drug Addiction—DRD4—attention deficit hyperactivity disorder	0.00953	0.0161	CbGpPWpGaD
Quinidine barbiturate—KCNH2—forebrain—attention deficit hyperactivity disorder	0.00899	0.0225	CbGeAlD
Quinidine barbiturate—GRIA2—Hypothetical Network for Drug Addiction—DRD2—attention deficit hyperactivity disorder	0.00888	0.015	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.00843	0.0143	CbGpPWpGaD
Quinidine barbiturate—GRIA2—brain—attention deficit hyperactivity disorder	0.00827	0.0207	CbGeAlD
Quinidine barbiturate—GABRA1—midbrain—attention deficit hyperactivity disorder	0.00826	0.0207	CbGeAlD
Quinidine barbiturate—CHRM2—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.00825	0.014	CbGpPWpGaD
Quinidine barbiturate—SCN5A—nervous system—attention deficit hyperactivity disorder	0.00794	0.0199	CbGeAlD
Quinidine barbiturate—SCN5A—central nervous system—attention deficit hyperactivity disorder	0.00764	0.0191	CbGeAlD
Quinidine barbiturate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00761	0.0129	CbGpPWpGaD
Quinidine barbiturate—KCNH2—cardiovascular system—attention deficit hyperactivity disorder	0.0076	0.019	CbGeAlD
Quinidine barbiturate—CHRM2—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.00708	0.012	CbGpPWpGaD
Quinidine barbiturate—GABRA2—nervous system—attention deficit hyperactivity disorder	0.00703	0.0176	CbGeAlD
Quinidine barbiturate—CHRM2—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.00694	0.0118	CbGpPWpGaD
Quinidine barbiturate—SCN5A—L1CAM interactions—ANK3—attention deficit hyperactivity disorder	0.00681	0.0115	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.00679	0.0115	CbGpPWpGaD
Quinidine barbiturate—GABRA1—nervous system—attention deficit hyperactivity disorder	0.00679	0.017	CbGeAlD
Quinidine barbiturate—GABRA2—central nervous system—attention deficit hyperactivity disorder	0.00677	0.0169	CbGeAlD
Quinidine barbiturate—CHRM2—nervous system—attention deficit hyperactivity disorder	0.00676	0.0169	CbGeAlD
Quinidine barbiturate—GABRA2—cerebellum—attention deficit hyperactivity disorder	0.00662	0.0166	CbGeAlD
Quinidine barbiturate—KCNK1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00657	0.0111	CbGpPWpGaD
Quinidine barbiturate—GABRA1—central nervous system—attention deficit hyperactivity disorder	0.00654	0.0164	CbGeAlD
Quinidine barbiturate—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.00651	0.0163	CbGeAlD
Quinidine barbiturate—GABRA1—cerebellum—attention deficit hyperactivity disorder	0.00639	0.016	CbGeAlD
Quinidine barbiturate—SCN5A—brain—attention deficit hyperactivity disorder	0.00607	0.0152	CbGeAlD
Quinidine barbiturate—KCNH2—midbrain—attention deficit hyperactivity disorder	0.00594	0.0149	CbGeAlD
Quinidine barbiturate—GABRA1—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.00579	0.00981	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00572	0.00968	CbGpPWpGaD
Quinidine barbiturate—KCNK1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00565	0.00956	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.00548	0.0137	CbGeAlD
Quinidine barbiturate—GABRA2—brain—attention deficit hyperactivity disorder	0.00537	0.0134	CbGeAlD
Quinidine barbiturate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00536	0.00907	CbGpPWpGaD
Quinidine barbiturate—KCNK1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00525	0.00889	CbGpPWpGaD
Quinidine barbiturate—GABRA1—brain—attention deficit hyperactivity disorder	0.00519	0.013	CbGeAlD
Quinidine barbiturate—CHRM2—brain—attention deficit hyperactivity disorder	0.00517	0.0129	CbGeAlD
Quinidine barbiturate—CHRM2—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.005	0.00847	CbGpPWpGaD
Quinidine barbiturate—KCNH2—nervous system—attention deficit hyperactivity disorder	0.00488	0.0122	CbGeAlD
Quinidine barbiturate—CHRM2—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.00481	0.00814	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00477	0.00807	CbGpPWpGaD
Quinidine barbiturate—KCNH2—central nervous system—attention deficit hyperactivity disorder	0.0047	0.0118	CbGeAlD
Quinidine barbiturate—KCNK1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00468	0.00792	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.00465	0.00787	CbGpPWpGaD
Quinidine barbiturate—KCNH2—cerebellum—attention deficit hyperactivity disorder	0.00459	0.0115	CbGeAlD
Quinidine barbiturate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00457	0.00773	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.0045	0.00763	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.00443	0.0075	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00438	0.00742	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.00437	0.0074	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.0042	0.00712	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.00407	0.0069	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00406	0.00688	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00403	0.00682	CbGpPWpGaD
Quinidine barbiturate—KCNK1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00398	0.00674	CbGpPWpGaD
Quinidine barbiturate—KCNK1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00395	0.00669	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.00391	0.00662	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00387	0.00655	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.00379	0.00641	CbGpPWpGaD
Quinidine barbiturate—KCNH2—brain—attention deficit hyperactivity disorder	0.00373	0.00934	CbGeAlD
Quinidine barbiturate—CHRM2—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.00372	0.0063	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.00367	0.00622	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00343	0.00581	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.00342	0.0058	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00335	0.00567	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.00325	0.00551	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.00315	0.00534	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00309	0.00522	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.00298	0.00745	CbGeAlD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00293	0.00496	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.00287	0.00717	CbGeAlD
Quinidine barbiturate—CHRM2—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00285	0.00483	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.0028	0.00701	CbGeAlD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.0028	0.00474	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.00271	0.00459	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00263	0.00446	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—GRM7—attention deficit hyperactivity disorder	0.00261	0.00442	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.0026	0.00441	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.0026	0.00441	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—ANK3—attention deficit hyperactivity disorder	0.00257	0.00436	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.00252	0.00427	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.00252	0.00427	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00252	0.00426	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.0024	0.00406	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00236	0.00399	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00234	0.00397	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00234	0.00396	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—brain—attention deficit hyperactivity disorder	0.00228	0.00569	CbGeAlD
Quinidine barbiturate—GRIA2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00224	0.0038	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—BDNF—attention deficit hyperactivity disorder	0.00221	0.00374	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.00214	0.00363	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00209	0.00353	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00206	0.00349	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00201	0.0034	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Other—DRD3—attention deficit hyperactivity disorder	0.002	0.00339	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00198	0.00336	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.00196	0.00332	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Other—DRD4—attention deficit hyperactivity disorder	0.00194	0.00329	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00193	0.00327	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.0019	0.00321	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.00189	0.0032	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.00184	0.00312	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.00184	0.00311	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.00183	0.0031	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.00181	0.00307	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00179	0.00304	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00177	0.003	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00177	0.003	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00176	0.00298	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00176	0.00298	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.00175	0.00297	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00174	0.00294	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.00171	0.0029	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.00171	0.0029	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.0017	0.00289	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.00168	0.00284	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00166	0.00281	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.00166	0.00281	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00165	0.00279	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00163	0.00275	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.0016	0.00271	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.0016	0.0027	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00159	0.0027	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00159	0.0027	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00158	0.00268	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00158	0.00268	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00158	0.00267	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.00155	0.00262	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00151	0.00256	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00148	0.00251	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00147	0.00249	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.00144	0.00244	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00141	0.0024	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00141	0.00239	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00141	0.00238	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00139	0.00236	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00136	0.00231	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00136	0.0023	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00136	0.0023	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00135	0.00228	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00135	0.00228	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.00134	0.00227	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.00134	0.00227	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.00129	0.00219	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.00129	0.00218	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.00127	0.00215	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00126	0.00214	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00125	0.00212	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00125	0.00211	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.00124	0.00211	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00124	0.0021	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.0012	0.00203	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00119	0.00202	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.00119	0.00201	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.00118	0.002	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00116	0.00196	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00113	0.00191	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.0011	0.00187	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00108	0.00182	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00106	0.0018	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00106	0.0018	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00106	0.0018	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00106	0.00179	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.00105	0.00178	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00104	0.00176	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00104	0.00176	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.00101	0.00171	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000974	0.00165	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000965	0.00163	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00096	0.00163	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000957	0.00162	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00095	0.00161	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000946	0.0016	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.000936	0.00159	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00092	0.00156	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.000909	0.00154	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000897	0.00152	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000894	0.00151	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000869	0.00147	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000854	0.00145	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.000847	0.00143	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000846	0.00143	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000844	0.00143	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000827	0.0014	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000823	0.00139	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.00082	0.00139	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000816	0.00138	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000812	0.00137	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00081	0.00137	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000786	0.00133	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000769	0.0013	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000745	0.00126	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000732	0.00124	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000723	0.00122	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00072	0.00122	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000673	0.00114	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00063	0.00107	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000605	0.00102	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.0006	0.00102	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000587	0.000995	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000585	0.000991	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000568	0.000962	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000567	0.00096	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000564	0.000955	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00056	0.000948	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000557	0.000944	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000557	0.000943	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00055	0.000932	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00055	0.000932	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000544	0.000922	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000533	0.000903	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000516	0.000874	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000513	0.000868	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000479	0.000812	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000472	0.000799	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000436	0.000739	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000407	0.000689	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000374	0.000634	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00037	0.000626	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000359	0.000608	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000356	0.000603	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000336	0.000569	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000331	0.00056	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000323	0.000547	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000322	0.000545	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00032	0.000543	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000315	0.000534	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000315	0.000533	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000311	0.000527	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000309	0.000523	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.0003	0.000509	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000291	0.000493	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00029	0.000491	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000286	0.000484	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000282	0.000478	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000263	0.000446	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000232	0.000393	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000218	0.00037	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000203	0.000344	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000191	0.000323	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000184	0.000312	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000177	0.000301	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000172	0.000291	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000169	0.000286	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000167	0.000283	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00016	0.000271	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00016	0.000271	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000158	0.000267	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000155	0.000263	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000147	0.000248	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000128	0.000217	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000122	0.000207	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000109	0.000184	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	9.71e-05	0.000164	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	9.64e-05	0.000163	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.77e-05	9.77e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	4.16e-05	7.05e-05	CbGpPWpGaD
